news Pembrolizumab Plus Chemoradiotherapy Under Review for High-Risk Locally Advanced Cervical Cancer The sBLA was based on efficacy and safety data from the KEYNOTE-A18 trial. By Brian Park, PharmD Publish Date September 20, 2023